Lifestyle and chronic kidney disease: A machine learning modeling study
Wenjin Luo(The Affiliated Yongchuan Hospital of Chongqing Medical University), Jinbo Hu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Linqiang Ma(The Affiliated Yongchuan Hospital of Chongqing Medical University), Chuan Peng(The Affiliated Yongchuan Hospital of Chongqing Medical University), Shumin Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yue Wang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Zhihong Wang(First Affiliated Hospital of Chongqing Medical University), Xiangjun Chen(The Affiliated Yongchuan Hospital of Chongqing Medical University), Zhiping Liu(Peking University), Bin Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Rufei Gao(Chongqing Public Health Medical Center), Qifu Li(First Affiliated Hospital of Chongqing Medical University), Ting Luo(The Affiliated Yongchuan Hospital of Chongqing Medical University), Mei Mei(Chinese Academy of Medical Sciences & Peking Union Medical College), Yi Yang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Lilin Gong(The Affiliated Yongchuan Hospital of Chongqing Medical University), Bing Kang(The Affiliated Yongchuan Hospital of Chongqing Medical University)
Cited by 27
Related Papers
In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus
|Journal of Integrative Medicine|2020|491
Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
|International Journal of Molecular Sciences|2020|153
Expressions of Nuclear Factor κB, Inducible Nitric Oxide Synthase, and Vascular Endothelial Growth Factor in Adenoid Cystic Carcinoma of Salivary Glands: Correlations with the Angiogenesis and Clinical Outcome
|Clinical Cancer Research|2005|134
Endothelial adenosine A2a receptor-mediated glycolysis is essential for pathological retinal angiogenesis
|Nature Communications|2017|120
Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples
|Journal of Nanobiotechnology|2021|82